Literature DB >> 26270469

Efficacy of sodium hypochlorite (bleach) baths to reduce Staphylococcus aureus colonization in childhood onset moderate-to-severe eczema: A randomized, placebo-controlled cross-over trial.

K L Hon1, Y C K Tsang2, V W Y Lee2, N H Pong1, Gladys Ha1, S T Lee1, C M Chow1, T F Leung1.   

Abstract

BACKGROUND: Staphylococcus aureus (S. aureus) colonization/infection is an important factor in the pathophysiology of atopic dermatitis (AD). Clinical trials have demonstrated conflicting efficacy of diluted bleach baths in treating moderate-to-severe AD. We conducted a double-blinded, placebo-controlled (water), cross-over trial among patients with AD to investigate the efficacy of bleach baths in reducing S. aureus colonization and AD severity.
METHOD: In this cross-over trial, 40 patients with moderate-to-severe AD were randomized to receive twice-weekly bleach and water baths, each for four consecutive weeks with a four-week wash-out period in between. Condition of S. aureus growth and SCORing Atopic Dermatitis index (SCORAD) were recorded at baseline and four-weekly intervals. Patients' blood was collected in first and second visits to investigate blood eosinophil count, serum levels of total IgE and specific IgEs against Staphylococcal enterotoxins A and B. In every visit, Children Dermatology Life Quality Index (CDLQI), skin hydration (SH), transepidermal water loss (TEWL) and usage frequency of prohibited medications (topical antibiotic, steroid and oral antihistamine) were recorded.
RESULTS: All 40 patients completed the trial, but 14 were non-adherent. By intention-to-treat (ITT) approach, comparing with water baths, bleach baths conferred no significant efficacy in CDLQI, SH, TEWL, blood eosinophil count, total IgE and the two specific IgEs over four weeks. Water baths caused a greater reduction in affected area of SCORAD than bleach baths (-5.7 ± 15.4 for water vs. 0.6 ± 12.4 for bleach; p = 0.03) by ITT, and in objective SCORAD and affected area (p < 0.05) from per-protocol approach. Bleach baths reduced topical corticosteroid use (mean difference = 1.1 ± 2.6 days/week; p = 0.014) and topical antibiotic use (mean difference = 1.0 ± 2.8 days/week; p = 0.044) in within-group analysis.
CONCLUSIONS: This study demonstrated that a four-week, twice-weekly regime of diluted bleach baths is not more useful than water baths in reducing S. aureus colonization/infection and improving AD. A longer treatment period is needed to evaluate if the short treatment duration was the main cause for the discrepancy in outcome from other bleach-bath trials. The usage of a portable bath tub obviates the problems associated with unavailability of bathing facilities in some families.

Entities:  

Keywords:  Atopic eczema; S. aureus; SCORAD; Staphylococcal enterotoxin; bleach bath; quality of life; randomized cross-over trial

Mesh:

Substances:

Year:  2015        PMID: 26270469     DOI: 10.3109/09546634.2015.1067669

Source DB:  PubMed          Journal:  J Dermatolog Treat        ISSN: 0954-6634            Impact factor:   3.359


  17 in total

Review 1.  The role of mineral elements and other chemical compounds used in balneology: data from double-blind randomized clinical trials.

Authors:  Carla Morer; Christian-François Roques; Alain Françon; Romain Forestier; Francisco Maraver
Journal:  Int J Biometeorol       Date:  2017-08-28       Impact factor: 3.787

Review 2.  Efficacy of bleach baths in reducing severity of atopic dermatitis: A systematic review and meta-analysis.

Authors:  Rishi Chopra; Paras P Vakharia; Ryan Sacotte; Jonathan I Silverberg
Journal:  Ann Allergy Asthma Immunol       Date:  2017-11       Impact factor: 6.347

3.  Interventions to reduce Staphylococcus aureus in the management of eczema.

Authors:  Susannah Mc George; Sanja Karanovic; David A Harrison; Anjna Rani; Andrew J Birnie; Fiona J Bath-Hextall; Jane C Ravenscroft; Hywel C Williams
Journal:  Cochrane Database Syst Rev       Date:  2019-10-29

Review 4.  Emollients and moisturisers for eczema.

Authors:  Esther J van Zuuren; Zbys Fedorowicz; Robin Christensen; Adriana Lavrijsen; Bernd WM Arents
Journal:  Cochrane Database Syst Rev       Date:  2017-02-06

Review 5.  Which Way Do We Go? Complex Interactions in Atopic Dermatitis Pathogenesis.

Authors:  Garrett J Patrick; Nathan K Archer; Lloyd S Miller
Journal:  J Invest Dermatol       Date:  2020-09-15       Impact factor: 8.551

Review 6.  Experimental Drugs with the Potential to Treat Atopic Eczema.

Authors:  Kam Lun Ellis Hon; Vivian P Y Chan; Alexander K C Leung
Journal:  J Exp Pharmacol       Date:  2021-05-12

Review 7.  Clinical approach to the patient with refractory atopic dermatitis.

Authors:  Neema Izadi; Donald Y M Leung
Journal:  Ann Allergy Asthma Immunol       Date:  2018-01       Impact factor: 6.347

8.  Atopic Dermatitis: Early Treatment in Children.

Authors:  Amy Huang; Christine Cho; Donald Y M Leung; Kanwaljit Brar
Journal:  Curr Treat Options Allergy       Date:  2017-08-01

Review 9.  Consensus Conference on Clinical Management of pediatric Atopic Dermatitis.

Authors:  Elena Galli; Iria Neri; Giampaolo Ricci; Ermanno Baldo; Maurizio Barone; Anna Belloni Fortina; Roberto Bernardini; Irene Berti; Carlo Caffarelli; Elisabetta Calamelli; Lucetta Capra; Rossella Carello; Francesca Cipriani; Pasquale Comberiati; Andrea Diociaiuti; Maya El Hachem; Elena Fontana; Michaela Gruber; Ellen Haddock; Nunzia Maiello; Paolo Meglio; Annalisa Patrizi; Diego Peroni; Dorella Scarponi; Ingrid Wielander; Lawrence F Eichenfield
Journal:  Ital J Pediatr       Date:  2016-03-02       Impact factor: 2.638

10.  Targeted anti-staphylococcal therapy with endolysins in atopic dermatitis and the effect on steroid use, disease severity and the microbiome: study protocol for a randomized controlled trial (MAAS trial).

Authors:  Joan Totté; Jill de Wit; Luba Pardo; Frank Schuren; Martijn van Doorn; Suzanne Pasmans
Journal:  Trials       Date:  2017-08-31       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.